• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

英国医疗卫生和社区检测中 SARS-CoV-2 感染的检出率。

Ascertainment rate of SARS-CoV-2 infections from healthcare and community testing in the UK.

机构信息

Royal (Dick) School of Veterinary Studies and the Roslin Institute, University of Edinburgh, Midlothian, UK.

Royal (Dick) School of Veterinary Studies and the Roslin Institute, University of Edinburgh, Midlothian, UK; Unit Veterinary Public Health and Epidemiology, University of Veterinary Medicine, Vienna, Austria; Complexity Science Hub Vienna, Austria.

出版信息

J Theor Biol. 2023 Feb 7;558:111333. doi: 10.1016/j.jtbi.2022.111333. Epub 2022 Nov 5.

DOI:10.1016/j.jtbi.2022.111333
PMID:36347306
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9636607/
Abstract

The proportion of SARS-CoV-2 infections ascertained through healthcare and community testing is generally unknown and expected to vary depending on natural factors and changes in test-seeking behaviour. Here we use population surveillance data and reported daily case numbers in the United Kingdom to estimate the rate of case ascertainment. We mathematically describe the relationship between the ascertainment rate, the daily number of reported cases, population prevalence, and the sensitivity of PCR and Lateral Flow tests as a function time since exposure. Applying this model to the data, we estimate that 20%-40% of SARS-CoV-2 infections in the UK were ascertained with a positive test with results varying by time and region. Cases of the Alpha variant were ascertained at a higher rate than the wild type variants circulating in the early pandemic, and higher again for the Delta variant and Omicron BA.1 sub-lineage, but lower for the BA.2 sub-lineage. Case ascertainment was higher in adults than in children. We further estimate the daily number of infections and compare this to mortality data to estimate that the infection fatality rate increased by a factor of 3 during the period dominated by the Alpha variant, and declined in line with the distribution of vaccines. This manuscript was submitted as part of a theme issue on "Modelling COVID-19 and Preparedness for Future Pandemics".

摘要

通过医疗保健和社区检测确定的 SARS-CoV-2 感染比例通常是未知的,预计会因自然因素和检测寻求行为的变化而有所不同。在这里,我们使用人群监测数据和英国报告的每日病例数来估计病例检出率。我们将检出率、每日报告病例数、人群流行率以及 PCR 和侧向流动测试的敏感性之间的关系用数学方法描述为暴露后时间的函数。将该模型应用于数据,我们估计英国 20%-40%的 SARS-CoV-2 感染通过阳性检测得到确定,结果因时间和地区而异。与大流行早期流行的野生型变异相比,Alpha 变体的病例检出率更高,Delta 变体和 Omicron BA.1 亚系更高,而 BA.2 亚系则更低。成人的病例检出率高于儿童。我们进一步估计了每日感染人数,并将其与死亡率数据进行比较,估计在 Alpha 变体主导的时期,感染病死率增加了 3 倍,并随着疫苗的分布而下降。本文是作为“建模 COVID-19 和为未来大流行做准备”主题特刊的一部分提交的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e7f/9636607/a2bc0995e5c8/gr8_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e7f/9636607/3fdf08e541e3/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e7f/9636607/55f3a1711873/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e7f/9636607/db0ea4585636/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e7f/9636607/b64e04581e71/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e7f/9636607/c28660f672de/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e7f/9636607/209740f8fde3/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e7f/9636607/032f0a1422db/gr7_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e7f/9636607/a2bc0995e5c8/gr8_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e7f/9636607/3fdf08e541e3/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e7f/9636607/55f3a1711873/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e7f/9636607/db0ea4585636/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e7f/9636607/b64e04581e71/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e7f/9636607/c28660f672de/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e7f/9636607/209740f8fde3/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e7f/9636607/032f0a1422db/gr7_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e7f/9636607/a2bc0995e5c8/gr8_lrg.jpg

相似文献

1
Ascertainment rate of SARS-CoV-2 infections from healthcare and community testing in the UK.英国医疗卫生和社区检测中 SARS-CoV-2 感染的检出率。
J Theor Biol. 2023 Feb 7;558:111333. doi: 10.1016/j.jtbi.2022.111333. Epub 2022 Nov 5.
2
Emerging Variants of SARS-CoV-2 and Novel Therapeutics Against Coronavirus (COVID-19)严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的新变种及针对冠状病毒(COVID-19)的新型疗法
3
Performance of antigen lateral flow devices in the UK during the alpha, delta, and omicron waves of the SARS-CoV-2 pandemic: a diagnostic and observational study.抗原侧向流动设备在英国 SARS-CoV-2 大流行的阿尔法、德尔塔和奥密克戎波期间的表现:一项诊断和观察性研究。
Lancet Infect Dis. 2023 Aug;23(8):922-932. doi: 10.1016/S1473-3099(23)00129-9. Epub 2023 Mar 28.
4
Estimating SARS-CoV-2 infections and associated changes in COVID-19 severity and fatality.估算 SARS-CoV-2 感染以及 COVID-19 严重程度和病死率的相关变化。
Influenza Other Respir Viruses. 2023 Aug 16;17(8):e13181. doi: 10.1111/irv.13181. eCollection 2023 Aug.
5
Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021-March, 2022: a national, observational, test-negative, case-control study.2021 年 8 月至 2022 年 3 月,英国青少年在先前感染和接种疫苗后对 delta(B.1.617.2)和 omicron(B.1.1.529)BA.1 和 BA.2 SARS-CoV-2 变异株的症状性感染的保护作用:一项全国性、观察性、基于检测的病例对照研究。
Lancet Infect Dis. 2023 Apr;23(4):435-444. doi: 10.1016/S1473-3099(22)00729-0. Epub 2022 Nov 24.
6
Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis.估算 2021 年 11 月 14 日前全球、区域和国家的 SARS-CoV-2 日感染和累计感染人数:一项统计分析。
Lancet. 2022 Jun 25;399(10344):2351-2380. doi: 10.1016/S0140-6736(22)00484-6. Epub 2022 Apr 8.
7
Early Warning Surveillance for SARS-CoV-2 Omicron Variants, United Kingdom, November 2021-September 2022.2021 年 11 月至 2022 年 9 月期间,英国针对 SARS-CoV-2 奥密克戎变异株的早期预警监测。
Emerg Infect Dis. 2023 Jan;29(1):184-188. doi: 10.3201/eid2901.221293. Epub 2022 Dec 1.
8
Autoimmune Sequelae After Delta or Omicron Variant SARS-CoV-2 Infection in a Highly Vaccinated Cohort.高度接种疫苗人群中德尔塔或奥密克戎变异株 SARS-CoV-2 感染后的自身免疫后遗症。
JAMA Netw Open. 2024 Aug 1;7(8):e2430983. doi: 10.1001/jamanetworkopen.2024.30983.
9
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
10
Acute and Postacute COVID-19 Outcomes Among Immunologically Naive Adults During Delta vs Omicron Waves.免疫功能正常成年人在德尔塔变异株与奥密克戎变异株流行期间的急性和后期 COVID-19 结局。
JAMA Netw Open. 2023 Feb 1;6(2):e231181. doi: 10.1001/jamanetworkopen.2023.1181.

引用本文的文献

1
Identification of undetected SARS-CoV-2 infections by clustering of Nucleocapsid antibody trajectories.通过核衣壳抗体轨迹聚类识别未检测到的新冠病毒感染
Nat Commun. 2025 May 14;16(1):4466. doi: 10.1038/s41467-025-57370-z.
2
Estimation of unconfirmed COVID-19 cases from a cross-sectional survey of >10 000 households and a symptom-based machine learning model in Gilgit-Baltistan, Pakistan.通过对巴基斯坦吉尔吉特-巴尔蒂斯坦地区10000多户家庭的横断面调查和基于症状的机器学习模型估算未确诊的新冠肺炎病例数。
BMJ Public Health. 2025 Apr 28;3(1):e001255. doi: 10.1136/bmjph-2024-001255. eCollection 2025 Jan.
3
Modeling the burden of long COVID in California with quality adjusted life-years (QALYS).

本文引用的文献

1
Longitudinal Analysis of SARS-CoV-2 Vaccine Breakthrough Infections Reveals Limited Infectious Virus Shedding and Restricted Tissue Distribution.新冠病毒疫苗突破性感染的纵向分析显示感染性病毒脱落有限且组织分布受限。
Open Forum Infect Dis. 2022 Apr 13;9(7):ofac192. doi: 10.1093/ofid/ofac192. eCollection 2022 Jul.
2
Daily longitudinal sampling of SARS-CoV-2 infection reveals substantial heterogeneity in infectiousness.每日纵向采样 SARS-CoV-2 感染揭示了传染性的显著异质性。
Nat Microbiol. 2022 May;7(5):640-652. doi: 10.1038/s41564-022-01105-z. Epub 2022 Apr 28.
3
Viral Dynamics of SARS-CoV-2 Variants in Vaccinated and Unvaccinated Persons.
用健康调整生命年(QALYs)对加利福尼亚州长新冠的负担进行建模。
Sci Rep. 2024 Sep 30;14(1):22663. doi: 10.1038/s41598-024-73160-x.
4
Jointly estimating epidemiological dynamics of Covid-19 from case and wastewater data in Aotearoa New Zealand.利用新西兰奥特亚罗瓦的病例和废水数据联合估计新冠疫情的流行病学动态。
Commun Med (Lond). 2024 Jul 15;4(1):143. doi: 10.1038/s43856-024-00570-3.
5
The effect of quarantine policy on pollution emission and the usage of private transportation in urban areas.隔离政策对城市地区污染排放和私人交通使用的影响。
Sci Rep. 2024 Jul 8;14(1):15752. doi: 10.1038/s41598-024-66685-8.
6
Estimating the Burden and Distribution of Post-COVID-19 Condition in Washington State, March 2020-October 2023.估算华盛顿州 2020 年 3 月至 2023 年 10 月期间新冠后疾病的负担和分布。
Prev Chronic Dis. 2024 Jun 27;21:E47. doi: 10.5888/pcd21.230433.
7
Drivers and impact of the early silent invasion of SARS-CoV-2 Alpha.SARS-CoV-2 Alpha 早期静默入侵的驱动因素和影响。
Nat Commun. 2024 Mar 9;15(1):2152. doi: 10.1038/s41467-024-46345-1.
8
Using early detection data to estimate the date of emergence of an epidemic outbreak.利用早期检测数据估计疫情爆发的日期。
PLoS Comput Biol. 2024 Mar 8;20(3):e1011934. doi: 10.1371/journal.pcbi.1011934. eCollection 2024 Mar.
9
Vaccination against COVID-19 - risks and benefits in children.儿童 COVID-19 疫苗接种 - 风险与获益。
Eur J Pediatr. 2024 Mar;183(3):1107-1112. doi: 10.1007/s00431-023-05380-8. Epub 2024 Jan 2.
10
Routine Surveillance of SARS-CoV-2 Serostatus in Pediatrics Allows Monitoring of Humoral Response.对儿科患者进行严重急性呼吸综合征冠状病毒2血清状态的常规监测有助于监测体液免疫反应。
Microorganisms. 2023 Dec 4;11(12):2919. doi: 10.3390/microorganisms11122919.
接种疫苗和未接种疫苗人群中新冠病毒变异株的病毒动力学
N Engl J Med. 2021 Dec 23;385(26):2489-2491. doi: 10.1056/NEJMc2102507. Epub 2021 Dec 1.
4
BNT162b2 and ChAdOx1 nCoV-19 Vaccine Effectiveness against Death from the Delta Variant.BNT162b2和ChAdOx1 nCoV-19疫苗对德尔塔变异株所致死亡的有效性
N Engl J Med. 2021 Dec 2;385(23):2195-2197. doi: 10.1056/NEJMc2113864. Epub 2021 Oct 20.
5
Virologic Features of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children.儿童严重急性呼吸综合征冠状病毒 2 感染的病毒学特征。
J Infect Dis. 2021 Dec 1;224(11):1821-1829. doi: 10.1093/infdis/jiab509.
6
Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study.在 COVID 症状研究应用程序的英国用户中,疫苗接种后 SARS-CoV-2 感染的风险因素和疾病特征:一项前瞻性、基于社区的、嵌套的病例对照研究。
Lancet Infect Dis. 2022 Jan;22(1):43-55. doi: 10.1016/S1473-3099(21)00460-6. Epub 2021 Sep 1.
7
Clinical and Virological Features of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern: A Retrospective Cohort Study Comparing B.1.1.7 (Alpha), B.1.351 (Beta), and B.1.617.2 (Delta).关注的严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)变异株的临床和病毒学特征:比较 B.1.1.7(阿尔法)、B.1.351(贝塔)和 B.1.617.2(德尔塔)的回顾性队列研究。
Clin Infect Dis. 2022 Aug 24;75(1):e1128-e1136. doi: 10.1093/cid/ciab721.
8
SARS-CoV-2 shedding dynamics across the respiratory tract, sex, and disease severity for adult and pediatric COVID-19.呼吸道内 SARS-CoV-2 的脱落动力学、性别和成人及儿童 COVID-19 的疾病严重程度。
Elife. 2021 Aug 20;10:e70458. doi: 10.7554/eLife.70458.
9
Accuracy of novel antigen rapid diagnostics for SARS-CoV-2: A living systematic review and meta-analysis.新型 SARS-CoV-2 抗原快速诊断准确性的系统评价和荟萃分析。
PLoS Med. 2021 Aug 12;18(8):e1003735. doi: 10.1371/journal.pmed.1003735. eCollection 2021 Aug.
10
Asymptomatic SARS-CoV-2 infection: A systematic review and meta-analysis.无症状 SARS-CoV-2 感染:系统评价和荟萃分析。
Proc Natl Acad Sci U S A. 2021 Aug 24;118(34). doi: 10.1073/pnas.2109229118.